Net Loss per Share (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2016

Dec. 31, 2015

Net Loss Per Share Tables

Potentially dilutive securities

	As of June 30,
	2016		2015
Stock options		4,679,092		2,843,041
Restricted stock awards		1,573,898		2,180,850
Preferred stock		20,662,200		23,148,000
Common stock warrants		8,876,336		5,959,668
Total		35,791,526		34,131,559

	Years Ended December 31,
	2015		2014
Stock options		3,243,041		44,615
MabVax Series A redeemable convertible preferred stock		—		137,607
MabVax Series B redeemable convertible preferred stock		—		156,247
MabVax Series C-1 redeemable convertible preferred stock		—		412,444
Series B redeemable convertible preferred stock		—		102,895
Series A-1 preferred stock		—		742,658
Series C preferred stock		—		47,023
Series D preferred stock		19,149,100		—
Series E preferred stock		3,333,300		—
Unvested restricted stock		2,300,850		—
Warrants to purchase common stock		7,209,668		—
Total		35,235,959		1,643,489